603883 Stock Overview
Operates pharmacy store chain in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
LBX Pharmacy Chain Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.11 |
| 52 Week High | CN¥28.38 |
| 52 Week Low | CN¥11.90 |
| Beta | 0.43 |
| 11 Month Change | 8.57% |
| 3 Month Change | 47.00% |
| 1 Year Change | -19.89% |
| 33 Year Change | -31.96% |
| 5 Year Change | -41.30% |
| Change since IPO | -37.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603883 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | -1.7% | -0.9% | -0.9% |
| 1Y | -19.9% | -11.0% | 5.4% |
Return vs Industry: 603883 underperformed the CN Consumer Retailing industry which returned -10.3% over the past year.
Return vs Market: 603883 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 603883 volatility | |
|---|---|
| 603883 Average Weekly Movement | 13.0% |
| Consumer Retailing Industry Average Movement | 7.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603883's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 603883's weekly volatility has increased from 8% to 13% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 40,881 | Li Wang | www.lbxdrugs.com |
LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.
LBX Pharmacy Chain Joint Stock Company Fundamentals Summary
| 603883 fundamental statistics | |
|---|---|
| Market cap | CN¥13.77b |
| Earnings (TTM) | CN¥842.61m |
| Revenue (TTM) | CN¥22.63b |
16.3x
P/E Ratio0.6x
P/S RatioIs 603883 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603883 income statement (TTM) | |
|---|---|
| Revenue | CN¥22.63b |
| Cost of Revenue | CN¥15.06b |
| Gross Profit | CN¥7.56b |
| Other Expenses | CN¥6.72b |
| Earnings | CN¥842.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.11 |
| Gross Margin | 33.42% |
| Net Profit Margin | 3.72% |
| Debt/Equity Ratio | 53.4% |
How did 603883 perform over the long term?
See historical performance and comparison